- Home
- UBER vs ABBV Comparison
UBER vs ABBV Comparison
Compare UBER & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UBER | ABBV |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.9B | 358.5B |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | UBER | ABBV |
|---|---|---|
| Price | $73.64 | $234.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 33 | 18 |
| Target Price | $107.03 | ★ $253.71 |
| AVG Volume (30 Days) | ★ 18.8M | 3.9M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | ★ 3.73 | N/A |
| EPS | 0.13 | ★ 0.39 |
| Revenue | $52,017,000,000.00 | ★ $61,160,000,000.00 |
| Revenue This Year | $14.41 | $11.87 |
| Revenue Next Year | $14.29 | $8.12 |
| P/E Ratio | ★ $535.96 | $601.87 |
| Revenue Growth | ★ 18.28 | 8.57 |
| 52 Week Low | $67.19 | $181.75 |
| 52 Week High | $101.99 | $244.81 |
Technical Indicators
Market Signals| Indicator | UBER | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 66.38 |
| Support Level | $72.48 | $220.11 |
| Resistance Level | $79.27 | $237.81 |
| Average True Range (ATR) | 2.30 | 5.28 |
| MACD | 0.34 | 0.87 |
| Stochastic Oscillator | 83.39 | 92.72 |
Price Performance
Historical ComparisonAbout UBER Uber Technologies Inc.
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing (eVTOL) technology. Uber operates in over 70 countries, with over 202 million users who order rides or food at least once a month.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.